keyword
https://read.qxmd.com/read/38634699/burden-of-impaired-sleep-and-its-improvement-through-topical-treatment-in-psoriasis-and-atopic-dermatitis
#1
JOURNAL ARTICLE
Caroline Mann, Matthias Dreher, Jan-Niklas Rothschmidt, Petra Staubach
INTRODUCTION: Patients with chronic inflammatory skin diseases often suffer from sleep disturbances. However, objective data on sleep architecture, especially to evaluate potential overall influences under therapy, are lacking. PATIENTS AND METHODS: Pilot study on sleep quality changes including psoriasis and atopic dermatitis patients before and 2 weeks after intensive topical treatment. In addition to disease activity rating, patient-rated outcomes for itch severity and sleep quality and polygraphy was performed before and after topical therapy...
April 18, 2024: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/38634619/theaflavin-3-3-digallate-protects-liver-and-kidney-functions-in-diabetic-rats-by-up-regulating-circ-itch-and-nrf2-signaling-pathway
#2
JOURNAL ARTICLE
Hongjuan Fu, Jianbo He, Cong Li, Chang Hui
Theaflavin-3,3'-digallate (TFDG) in black tea has a strong antioxidant capacity. However, its effect on diabetic liver and kidney injury and the underlying mechanisms remain unclear. In the present study, our findings indicated that TFDG administration effectively lowers the fasting blood glucose and serum lipid concentrations and enhances the functionality and cellular architecture of the liver and kidney in rats with diabetes. The data also showed that TFDG mitigates oxidative harm in the liver and kidney of rats afflicted with diabetes...
April 18, 2024: Journal of Agricultural and Food Chemistry
https://read.qxmd.com/read/38631864/long-non-coding-rna-nuclear-enriched-abundant-transcript-1-neat1-facilitates-foam-cell-formation-and-atherosclerosis-progression-through-the-mir-17-5p-itchy-e3-ubiquitin-protein-ligase-itch-liver-kinase-b1-lkb1-axis
#3
JOURNAL ARTICLE
Haifen Huang, Bin Peng, Qingyong Chen, Yi Wang, Ren Li
BACKGROUND: Foam cell formation is an important step for atherosclerosis (AS) progression. We investigated the mechanism by which the long non-coding RNA (lncRNA) nuclear-enriched abundant transcript 1 (NEAT1) regulates foam cell formation during AS progression.Methods and Results: An in vivo AS model was created by feeding ApoE-/- mice a high-fat diet. Oxidized low-density lipoprotein (ox-LDL)-stimulated macrophages were used as a cellular AS model. Interactions between NEAT1, miR-17-5p, itchy E3 ubiquitin protein ligase (ITCH) and liver kinase B1 (LKB1) were analyzed...
April 16, 2024: Circulation Journal: Official Journal of the Japanese Circulation Society
https://read.qxmd.com/read/38631843/the-regulation-of-the-pd-1-pd-l1-pathway-in-imiquimod-induced-chronic-psoriasis-itch-and-itch-sensitization-in-mouse
#4
JOURNAL ARTICLE
Zhehao Xu, Yue Wang, Changcheng Jiang, Zhengwei Wang, Yongfeng Chen, Manli Fan
PD-1/PD-L1 inhibitors have been demonstrated to induce itch in both humans and experimental animals. However, whether the PD-1/PD-L1 pathway is involved in the regulation of chronic psoriatic itch remains unclear. This study aimed to investigate the role of the PD-1/PD-L1 pathway in imiquimod-induced chronic psoriatic itch. The intradermal injection of PD-L1 in the nape of neck significantly alleviated chronic psoriatic itch in imiquimod-treated skin. Additionally, we observed that spontaneous scratching behavior induced by imiquimod disappeared on day 21...
April 17, 2024: Molecular Pain
https://read.qxmd.com/read/38629497/efficacy-and-safety-of-nemolizumab-and-topical-corticosteroids-for-prurigo-nodularis-results-from-a-randomised-double-blind-placebo-controlled-phase-ii-iii-clinical-study-in-patients-aged-%C3%A2-13-years
#5
JOURNAL ARTICLE
Hiroo Yokozeki, Hiroyuki Murota, Takayo Matsumura, Hiroshi Komazaki
BACKGROUND: Prurigo nodularis, a chronic inflammatory skin condition, adversely affects the quality of life of affected individuals. Current treatment options for prurigo nodularis in Japan are limited. OBJECTIVES: To evaluate the optimal dose, efficacy, and safety of long-term treatment with nemolizumab in patients with prurigo nodularis in Japan. METHODS: In a 16-week, double-blind, phase II/III study, patients aged ≥13 years with prurigo nodularis were randomly assigned (1:1:1) to nemolizumab 30 mg, 60 mg, or placebo groups, with concomitant topical corticosteroids, every 4 weeks...
April 17, 2024: British Journal of Dermatology
https://read.qxmd.com/read/38623321/different-doses-and-courses-of-omalizumab-for-patients-with-chronic-spontaneous-urticaria-a-systematic-review-with-meta-analysis-and-trial-sequential-analysis
#6
JOURNAL ARTICLE
Haiyan Qin, Xianjun Xiao, Di Qin, Peiwen Xue, Huilin Liu, Ying Li, Yunzhou Shi
BACKGROUND: The stability, efficacy, and safety of omalizumab at different doses and regimens for chronic spontaneous urticaria (CSU) are yet to be studied. OBJECTIVE: A systematic review (SR) with meta-analysis (MA) and trial sequential analysis (TSA) was performed to assess the efficacy and safety of omalizumab in CSU. METHODS: Randomised controlled trials (RCTs) of administering omalizumab versus placebo for CSU were searched. Random-effects MAs were performed using planned subgroup analyses...
April 2024: World Allergy Organization Journal
https://read.qxmd.com/read/38623100/an-interesting-case-of-macular-amyloidosis-with-no-significant-etiology
#7
Avni Gakkhar, Ashok M Mehendale, Shivansh Mehendale
Macular amyloidosis is primary localized cutaneous amyloidosis (PLCA). It is described by the extracellular accumulation of heterogenic amyloid proteins in the skin that does not affect the systemic immune system, causing hyperpigmented patches. It is a prevalent skin disorder of young female adults, especially in India, since it affects the population with darker skin. History of frictional rub on the skin is typically present, such as using loofah or bathing scrubs or stones. The case presented below is of a 23-year-old female who presented with a hyperpigmented patch on the upper back of both sides and extensor surface of arms and did not have any history of usage of loofah on those areas, compelling us to research more on the other causative factors (genetic predisposition, infectious agents, and UV radiation are probable causative factors) for macular amyloidosis...
March 2024: Curēus
https://read.qxmd.com/read/38621466/comparing-chinese-herbal-medicine-bath-therapy-with-topical-calcipotriol-for-psoriasis-vulgaris-a-systematic-review-with-meta-analysis-and-association-rule-analysis
#8
REVIEW
Junyue Wang, Claire Shuiqing Zhang, Anthony Lin Zhang, Charlie Changli Xue, Chuanjian Lu
ETHNOPHARMACOLOGICAL RELEVANCE: Psoriasis is a chronic inflammatory skin disease. Vitamin D analogues are the first-line topical agents for the long-term management of psoriasis. Chinese herbal medicine (CHM) bath therapy is commonly employed for psoriasis. However, the effects and safety of CHM bath therapy compared with topical calcipotriol for psoriasis vulgaris remain inconclusive. Furthermore, the combination of herbs, a distinctive feature of CHM, is essential for its therapeutic effects due to the individual and synergistic properties of the herbs involved...
April 13, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38621336/inhibition-of-macrophage-mapk-nf-%C3%AE%C2%BAb-pathway-and-th2-axis-by-mangiferin-ameliorates-mc903-induced-atopic-dermatitis
#9
JOURNAL ARTICLE
Cheng Lu, ShiJun Deng, YanJiao Liu, ShengJin Yang, DingMei Qin, LiJuan Zhang, Rui-Rui Wang, Yi Zhang
Available online Atopic dermatitis (AD) is a chronic, persistent inflammatory skin disease characterized by eczema-like lesions and itching. Although topical steroids have been reported for treating AD, they are associated with adverse effects. Thus, safer medications are needed for those who cannot tolerate these agents for long periods. Mangiferin (MAN) is a flavonoid widely found in many herbs, with significant anti-inflammatory and immunomodulatory activities. However, the potential modulatory effects and mechanisms of MAN in treating Th2 inflammation in AD are unknown...
April 14, 2024: International Immunopharmacology
https://read.qxmd.com/read/38616484/successful-treatment-of-dyshidrotic-palmoplantar-eczema-with-tralokinumab
#10
Nisha V Parmar, Anwar Al Hammadi
Dyshidrotic palmoplantar eczema or pompholyx is considered to be a part of the spectrum of atopic dermatitis with a significant impact on the quality of life and limited treatment options. Tralokinumab is a new fully human monoclonal antibody which neutralizes interleukin 13, a chief cytokine in itch pathogenesis and skin barrier defects. Tralokinumab is FDA-approved for the treatment of atopic dermatitis in adults and EMA-approved for the treatment of atopic dermatitis in adults and adolescents. We, hereby, report a 40-year-old female with severe dyshidrotic palmoplantar eczema who was successfully treated with tralokinumab...
April 14, 2024: Australasian Journal of Dermatology
https://read.qxmd.com/read/38616301/artificial-intelligence-based-prescription-of-personalized-scalp-cosmetics-improved-the-scalp-condition-efficacy-results-from-100-participants
#11
JOURNAL ARTICLE
Bo Ri Kim, Min Jae Kim, Jieun Koo, Hwa-Jung Choi, Kyung Ho Paik, Soon Hyo Kwon, Hye-Ryung Choi, Chang Hun Huh, Jung Won Shin, Dong-Sun Park, Jung-Im Na
Background: Scalp-related symptoms such as dandruff and itching are common with diverse underlying etiologies. We previously proposed a novel classification and scoring system for scalp conditions, called the scalp photographic index (SPI); it grades five scalp features using trichoscopic images with good reliability. However, it requires trained evaluators. Aim: To develop artificial intelligence (AI) algorithms for assessment of scalp conditions and to assess the feasibility of AI-based recommendations on personalized scalp cosmetics...
December 2024: Journal of Dermatological Treatment
https://read.qxmd.com/read/38615978/prelimbic-cortex-nucleus-accumbens-core-projection-positively-regulates-itch-and-itch-related-aversion
#12
JOURNAL ARTICLE
Jun-Hui Long, Pu-Jun Wang, Li Xuan, Yao Juan, Guang-Yan Wu, Jun-Fei Teng, Jian-Feng Sui, Ya-Min Li, Liu Yang, Hong-Li Li, Shu-Lei Liu
Itch is one of the most common clinical symptoms in patients with diseases of the skin, liver, or kidney, and it strongly triggers aversive emotion and scratching behavior. Previous studies have confirmed the role of the prelimbic cortex (Prl) and the nucleus accumbens core (NAcC), which are reward and motivation regulatory centers, in the regulation of itch. However, it is currently unclear whether the Prl-NAcC projection, an important pathway connecting these two brain regions, is involved in the regulation of itch and its associated negative emotions...
April 12, 2024: Behavioural Brain Research
https://read.qxmd.com/read/38615134/novel-topical-treatments-for-itch
#13
REVIEW
Rami H Mahmoud, Omar Mahmoud, Georgia Biazus Soares, Gil Yosipovitch
The experience of itch often poses a burden on patient quality of life and has the capacity to inflict significant suffering. Topical therapies are a mainstay of treatment for many cutaneous and systemic diseases and afford patients the opportunity to manage their conditions without many of the systemic side effects of non-topical therapies. We review a multitude of new topical medications targeting the skin, immune system, and neural receptors. The list includes Janus kinase inhibitors, tyrosine kinase inhibitors, phosphodiesterase inhibitors, transient receptor vanilloid inhibitors, topical cannabinoids, and topical acetaminophen...
April 13, 2024: Dermatology and Therapy
https://read.qxmd.com/read/38613839/sodium-bile-acid-co-transporter-inhibitors-currently-in-preclinical-or-early-clinical-development-for-the-treatment-of-primary-biliary-cholangitis
#14
REVIEW
Abhishek Gairola, Aaron Wetten, Jessica Dyson
INTRODUCTION: Pruritus is common and often undertreated in patients with primary biliary cholangitis (PBC). Existing treatments largely have an aging and low-quality evidence base, and studies included only small numbers of patients. More recent data that has added to our understanding of pruritus treatments has often come from clinical trials where itch was a secondary outcome measure in a trial designed primarily to assess disease modifying agents. This area represents an unmet clinical need in the management of PBC...
April 13, 2024: Expert Opinion on Investigational Drugs
https://read.qxmd.com/read/38613531/beyond-the-surface-a-narrative-review-examining-the-systemic-impacts-of-recessive-dystrophic-epidermolysis-bullosa
#15
REVIEW
Courtney Popp, William Miller, Cindy Eide, Jakub Tolar, John A McGrath, Christen L Ebens
Recessive dystrophic epidermolysis bullosa (RDEB) is a rare genetic disease resulting from inadequate type VII collagen (C7). Although recurrent skin blisters and wounds are the most apparent disease features, the impact of C7 loss is not confined to the skin and mucous membranes. RDEB is a systemic disease marred by chronic inflammation, fibrotic changes, pain, itch, and anemia, significantly impacting QOL and survival. In this narrative review, we summarize these systemic features of RDEB and promising research avenues to address them...
April 12, 2024: Journal of Investigative Dermatology
https://read.qxmd.com/read/38612830/the-plight-of-the-metabolite-oxidative-stress-and-tear-film-destabilisation-evident-in-ocular-allergy-sufferers-across-seasons-in-victoria-australia
#16
JOURNAL ARTICLE
Esrin Aydin, Damien L Callahan, Luke Chong, Serap Azizoglu, Moneisha Gokhale, Cenk Suphioglu
Ocular allergy (OA) is characterised by ocular surface itchiness, redness, and inflammation in response to allergen exposure. The primary aim of this study was to assess differences in the human tear metabolome and lipidome between OA and healthy controls (HCs) across peak allergy (spring-summer) and off-peak (autumn-winter) seasons in Victoria, Australia. A total of 19 participants (14 OA, 5 HCs) aged 18-45 were recruited and grouped by allergy questionnaire score. Metabolites and lipids from tear samples were analysed using mass spectrometry...
April 4, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612578/liquiritin-carbomer-gel-cold-paste-promotes-healing-of-solar-dermatitis-in-mice
#17
JOURNAL ARTICLE
Yanfang Huang, Sijia Li, Jinghua Pan, Congjing Song, Weiqiang Chen, Yun Zhang
Ultraviolet radiation (UVR) has various effects on human cells and tissues, which can lead to a variety of skin diseases and cause inconvenience to people's lives. Among them, solar dermatitis is one of the important risk factors for malignant melanoma, so prevention and treatment of solar dermatitis is very necessary. Additionally, liquiritin (LQ) has anti-inflammatory effects. In this study, we aimed to evaluate the anti-inflammatory and pro-wound healing effects of liquiritin carbomer gel cold paste (LQ-CG-CP) in vitro and in vivo...
March 28, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38611845/evaluation-of-antioxidant-activity-and-treatment-of-eczema-by-berberine-hydrochloride-loaded-liposomes-in-gel
#18
JOURNAL ARTICLE
Si Shen, Xiaobo Qu, Yinyin Liu, Mengmeng Wang, Haifeng Zhou, Hongmei Xia
In this paper, berberine hydrochloride-loaded liposomes-in-gel were designed and developed to investigate their antioxidant properties and therapeutic effects on the eczema model of the mouse. Berberine hydrochloride-liposomes (BBH-L) as the nanoparticles were prepared by the thin-film hydration method and then dispersed BBH-L evenly in the gel matrix to prepare the berberine hydrochloride liposomes-gel (BBH-L-Gel) by the natural swelling method. Their antioxidant capacity was investigated by the free radical scavenging ability on 2,2-diphenyl-1-picrylhydrazyl (DPPH) and H2 O2 and the inhibition of lipid peroxides malondialdehyde (MDA)...
March 31, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38608833/human-merkel-cells-as-the-initiator-of-mechanotransduction-in-skin-linking-the-animal-model-to-humans
#19
JOURNAL ARTICLE
Saito Sakaguchi, Moe Tsutsumi, Shinsuke Akita, Masashi Konyo, Kentaro Kajiya
No abstract text is available yet for this article.
April 10, 2024: Journal of Investigative Dermatology
https://read.qxmd.com/read/38607195/treatment-of-netherton-syndrome-in-pediatrics-with-upadacitinib
#20
JOURNAL ARTICLE
Cuicui Sun, Yongfeng Chen
BACKGROUND: Netherton syndrome, a rare autosomal recessive genetic disease, lacks effective treatment options. This article presents a novel case of successful Upadacitinib therapy in a 14-year-old boy with Netherton syndrome. CASE PRESENTATION: A 14-year-old male with a lifelong history of dry skin, erythema, scaling, itching, and notable body odor was evaluated. These symptoms, accompanied by irregular hair growth and delayed development, prompted an initial diagnosis of atopic dermatitis at a local hospital...
April 12, 2024: Alternative Therapies in Health and Medicine
keyword
keyword
45256
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.